Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

CD137 ligand interacts with CD32a to trigger reverse CD137 ligand signaling

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1


  1. Mbanwi, A. N. & Watts, T. H. Costimulatory TNFR family members in control of viral infection: outstanding questions. Sem. Immunol. 26, 210–219 (2014).

    Article  CAS  Google Scholar 

  2. Zapata, J. M. et al. CD137 (4-1BB) signalosome: complexity is a matter of TRAFs. Front. Immunol. 9, 2618 (2018).

    Article  Google Scholar 

  3. Lee, S. W. & Croft, M. 4-1BB as a therapeutic target for human disease. Adv. Exp. Med. Biol. 647, 120–129 (2009).

    Article  CAS  Google Scholar 

  4. Shao, Z. & Schwarz, H. CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J. Leukoc. Biol. 89, 21–29 (2011).

    Article  CAS  Google Scholar 

  5. Kwajah, M. M. S. & Schwarz, H. CD137 ligand signaling induces human monocyte to dendritic cell differentiation. Eur. J. Immunol. 40, 1938–1949 (2010).

    Article  Google Scholar 

  6. Harfuddin, Z., Kwajah, S., Chong Nyi Sim, A., Macary, P. A. & Schwarz, H. CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses. Oncoimmunol. 2, e26859 (2013).

    Article  Google Scholar 

  7. Dharmadhikari, B. et al. CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8(+) T cells to Tc1 phenotype. Cancer Immunol. Immunother. 67, 893–905 (2018).

    Article  CAS  Google Scholar 

  8. Tang, Q., Jiang, D., Shao, Z., Martinez Gomez, J. M. & Schwarz, H. Species difference of CD137 ligand signaling in human and murine monocytes. PLoS ONE. 6, e16129 (2011).

    Article  CAS  Google Scholar 

  9. Alderson, M. R. et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24, 2219–2227 (1994).

    Article  CAS  Google Scholar 

  10. Harfuddin, Z. et al. Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype. Sci. Rep. 6, 29712 (2016).

    Article  CAS  Google Scholar 

Download references


This research was supported by a grant (NMRC/BnB/018b/2015) from the National Medical Research Council of Singapore. We thank the LSI core facility, Dr. Paul MacAry for the donation of WT and LALA-mutated antibodies, and the YLLSOM Confocal Microscopy Unit.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Herbert Schwarz.

Ethics declarations

Competing interests

The authors declare no competing interests.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zeng, Q., Soe, Y.M., Lim, Y. et al. CD137 ligand interacts with CD32a to trigger reverse CD137 ligand signaling. Cell Mol Immunol 17, 1188–1189 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links